Published: 16 July 2025
Committees
Comments on agenda items for the 74th meeting of the Medicines Classification Committee to be held on 23 July 2025.
The Medicines Classification Committee and the Secretariat wish to thank everyone for their valuable input and feedback.
A total of ten submissions (PDF 1.82MB, 31 pages) commenting on agenda items for the 74th meeting were received. Some of the submissions commented on more than one agenda item. Some parts of the comments have been withheld from publication pursuant to the Official Information Act 1982.
Agenda Item 5.1 Tenofovir disoproxil and emtricitabine
Three comments were received about this agenda item.
Agenda Item 5.2 Respiratory syncytial virus (RSV) vaccine
Two comments were received about this agenda item.
Agenda Item 5.3 Bilastine
One comment was received about this agenda item.
Agenda Item 5.4 Lithium
One comment was received about this agenda item.
Agenda Item 5.5 Vitamin D
One comment was received about this agenda item.
Agenda Item 5.6 Liquid paracetamol
Six comments were received about this agenda item.
Agenda Item 5.7 Peptide groups
One comment was received about this agenda item.
Agenda Item 7.2a Desloratadine
One comment was received about this agenda item.
Agenda Item 7.2b Atropa belladonna
One comment was received about this agenda item.
Agenda Item 8.2 Brimonidine
Three comments were received about this agenda item.
Agenda Item 8.3 Sedating antihistamines
One comment was received about this agenda item.
Agenda Item 8.4 Cetirizine
One comment was received about this agenda item.
